Immunosuppressive drugs are used in the treatment of inflammatory and autoimmune
diseases, as well as in transplantation. Frequently prescribed in young people, these …

Most patients with ulcerative colitis (UC) have mild-to-moderate disease activity, with low risk
of colectomy, and are managed by primary care physicians or gastroenterologists. Optimal …

2. Methods This document represents the third version of the European Consensus on
reproduction in IBD. The development of this Consensus included the formulation of …

Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen
Schreiber6, 7, Subha Arthanari8, Joel Cunningham3, Lucy Flanders3, Louise Moore9, Amy …

Objective The incidence of inflammatory bowel disease (IBD) is increasing in Eastern
Europe. The reasons for these changes remain unknown. The aim of this study was to …

OBJECTIVES: The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα)
drugs during pregnancy has received little attention. We aimed to compare the relative risk …

Background The rate of exacerbation of inflammatory bowel disease (IBD) during pregnancy
varies in the published literature. Aim We sought to perform a systematic review and meta …

Background Vedolizumab is a gut‐selective immunoglobulin G1 monoclonal antibody to
α4β7 integrin for the treatment of Crohn's disease (CD) and ulcerative colitis (UC) …

Introduction: The advent of tumor necrosis factor (TNF) antagonists represented a radical
change in the management of inflammatory bowel disease (IBD). Both in short-and long …

Crohn's disease is a chronic inflammatory disorder that can affect any part of the
gastrointestinal tract. Although the disease most commonly presents at a young age, it can …